-transparent.png){kind=logo}
Five tables are presented that provide guidelines for drug usage in patients with renal insufficiency. The data are derived from the current medical literature. If specific information about a drug is unavailable, emphasis is given to normal pharmacokinetic variables in arriving at recommendations for therapy. Nephrotoxicity of adverse effects in patients with renal disease are noted and adjustments for dialysis suggested.
Related Publications
W M Bennett, and
I Singer, and
T Golper, and
P Feig, and
C J Coggins
January 2003,
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia,
W M Bennett, and
I Singer, and
T Golper, and
P Feig, and
C J Coggins
June 1977,
JAMA,
W M Bennett, and
I Singer, and
T Golper, and
P Feig, and
C J Coggins
February 2004,
Pediatric nephrology (Berlin, Germany),
W M Bennett, and
I Singer, and
T Golper, and
P Feig, and
C J Coggins
March 2001,
Report on medical guidelines & outcomes research,
W M Bennett, and
I Singer, and
T Golper, and
P Feig, and
C J Coggins
November 1971,
District nursing,
W M Bennett, and
I Singer, and
T Golper, and
P Feig, and
C J Coggins
August 1980,
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
W M Bennett, and
I Singer, and
T Golper, and
P Feig, and
C J Coggins
May 1982,
Comprehensive therapy,
W M Bennett, and
I Singer, and
T Golper, and
P Feig, and
C J Coggins
November 1980,
The Veterinary clinics of North America. Small animal practice,
W M Bennett, and
I Singer, and
T Golper, and
P Feig, and
C J Coggins
January 1980,
Annual review of pharmacology and toxicology,
W M Bennett, and
I Singer, and
T Golper, and
P Feig, and
C J Coggins
November 1973,
Medical times,
